… to 18 months. I’m grateful to our existing investors … Tom Frohlich as chief business officer, Alan Glicklich, M.D., as chief medical … Andrew King, D.V.M., Ph.D., as head of renal discovery … securityholders of Aduro as of immediately prior to the Merger, Aduro’s …
VIEW ARTICLE
If you would like to know more regarding the topic in this blog post, please do not hesitate to contact us.